Pharmacokinetics of Fentanyl Sublingual Spray in Opioid-Naïve Participants: Results of a Phase 1, Multiple Ascending Dose Study

被引：0
|
作者：
Richard L. Rauck
D. Alexander Oh
Neil Singla
Christian Koch
Neha Parikh
Srinivas Nalamachu
Jin Yu
Steven James
机构：
[1] Carolinas Pain Institute and The Center for Clinical Research,
[2] Insys Development Company,undefined
[3] Inc,undefined
[4] Lotus Clinical Research,undefined
[5] LLC,undefined
[6] Mid America PolyClinic,undefined
来源：
Clinical Drug Investigation | 2018年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：715 / 726
页数：11
相关论文
共 50 条
  • [1] Pharmacokinetics of Fentanyl Sublingual Spray in Opioid-Na⟨ve Participants: Results of a Phase 1, Multiple Ascending Dose Study
    Rauck, Richard L.
    Oh, D. Alexander
    Singla, Neil
    Koch, Christian
    Parikh, Neha
    Nalamachu, Srinivas
    Yu, Jin
    James, Steven
    CLINICAL DRUG INVESTIGATION, 2018, 38 (08) : 715 - 726
  • [2] Pharmacokinetics and safety of fentanyl sublingual spray and fentanyl citrate intravenous: a multiple ascending dose study in opioid-naive healthy volunteers
    Rauck, Richard L.
    Oh, D. Alexander
    Singla, Neil
    Koch, Christian
    Parikh, Neha
    Nalamachu, Srinivas
    Wilson, Daniel
    Yu, Jin
    Vetticaden, Santosh
    CURRENT MEDICAL RESEARCH AND OPINION, 2017, 33 (11) : 1921 - 1933
  • [3] Comparison of Analgesic Efficacy and Safety of Low-Dose Transdermal Fentanyl and Oral Oxycodone in Opioid-Naïve Patients with Cancer Pain
    Kawana, Mariko
    Miyasato, Akime
    Funato, Miyui
    Nagatani, Keigo
    Suzuki, Norifumi
    Onoda, Chiharu
    Fujimoto, Hidenori
    Ohno, Rintaro
    Kusakabe, Ayuko
    Kiribayashi, Mio
    Nakamura, Kazuyo
    Kondo, Masayoshi
    Ozeki, Ayumi
    Okamoto, Kousuke
    Kokubun, Hideya
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2023, 46 (10) : 1444 - 1450
  • [4] Pharmacokinetics and Dose Proportionality of Fentanyl Sublingual Spray: a Single-Dose 5-Way Crossover Study
    Neha Parikh
    Venkat Goskonda
    Ashok Chavan
    Larry Dillaha
    Clinical Drug Investigation, 2013, 33 : 391 - 400
  • [5] Pharmacokinetics and Dose Proportionality of Fentanyl Sublingual Spray: a Single-Dose 5-Way Crossover Study
    Parikh, Neha
    Goskonda, Venkat
    Chavan, Ashok
    Dillaha, Larry
    CLINICAL DRUG INVESTIGATION, 2013, 33 (06) : 391 - 400
  • [6] Efficacy and Safety of Fentanyl Citrate Patch, Including a Low-Dose 0.5 mg Formulation, in Opioid-Naïve Patients with Cancer Pain
    Shigeki Yamaguchi
    Eiji Uchida
    Takaaki Terahara
    Koji Okawa
    Fumitaka Hashimoto
    Yusuke Tanaka
    Clinical Drug Investigation, 2020, 40 : 1041 - 1052
  • [7] Single-Dose Pharmacokinetics of Fentanyl Sublingual Spray and Oral Transmucosal Fentanyl Citrate in Healthy Volunteers: A Randomized Crossover Study
    Parikh, Neha
    Goskonda, Venkat
    Chavan, Ashok
    Dillaha, Larry
    CLINICAL THERAPEUTICS, 2013, 35 (03) : 236 - 243
  • [8] A phase 1 multiple-ascending dose study of tirzepatide in Japanese participants with type 2 diabetes
    Furihata, Kenichi
    Mimura, Hanaka
    Urva, Shweta
    Oura, Tomonori
    Ohwaki, Kenji
    Imaoka, Takeshi
    DIABETES OBESITY & METABOLISM, 2022, 24 (02): : 239 - 246
  • [9] PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY RESULTS FROM A PHASE 1 MULTIPLE ASCENDING DOSE STUDY OF THE SELECTIVE ALDOSTERONE SYNTHASE INHIBITOR CIN-107
    Freeman, Mason W.
    Bond, Mary
    Murphy, Brian
    Hui, James
    Isaacson, Jonathan
    JOURNAL OF HYPERTENSION, 2023, 41 : E42 - E43
  • [10] Safety and Pharmacokinetics of Single-Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study
    Xu, Junyu
    Xie, Ran
    Ji, Yongjia
    Qian, Chenxi
    Zhang, Xin
    Todd, Kris
    Wang, Feng
    Cui, Yimin
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2024, 13 (10): : 1143 - 1150
12345